半乳糖凝集素9(GAL9)活性蛋白
Active Galectin 9 (GAL9)
LGALS9; Ecalectin; Lectin,Galactoside-Binding Soluble 9; Tumor antigen HOM-HD-21
- 編號(hào)APA309Mu02
 - 物種Mus musculus (Mouse,小鼠)相同的名稱,不同的物種。
 - 緩沖液成份磷酸鹽緩沖液(pH7.4,含有 0.01% SKL, 1mM DTT, 5% Trehalose和Proclin300.)
 - 性狀凍干粉
 - 純度> 90%
 - 等電點(diǎn)7.2
 - 應(yīng)用Cell?culture;?Activity?Assays.
 - 下載英文說明書 中文說明書
 - 規(guī)格10μg50μg200μg1mg5mg
 - 價(jià)格¥ 1798¥ 4494¥ 8988¥ 26964¥ 67410
 - 欲了解實(shí)際交易價(jià)格和更多情況,請(qǐng)與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
 
活性實(shí)驗(yàn)

Galectin 9 (GAL9) is a member of the β-galactoside–binding galectin family. Galectin-9 is found outside of cells and may be exported by non-classical pathways. Galectin 9 exhibits a variety of biological activities, the majority of which have focused on its immunomodulatory role toward lymphocytes, were it shows specific interactions with TIM-3, and can negatively regulate Th1 type immunity. It also can agglutinate red blood.In this case, we chose rabbit erythrocyte (RaE) to assay its ability of agglutination. A general procedure for hemagglutination assay (or haemagglutination assay; HA) is as follows, two-fold dilute the recombinant Mu GAL9 with 0.9% sodium chloride injection, add 50μL a serial dilution of GAL9 to each well of a U or V-bottom shaped 96-well microtiter plate. The final well serves as a negative control with no GAL9, replace with 50μL 0.9% sodium chloride injection. Then add 50μL 1% rabbit erythrocyte to each well and mixed gently. The plate is incubated for 3 hours at room temperature. The results are shown in Figure 1. It was obvious that the minimal effective concentration of GAL9 is 6.25 μg/mL.

Figure 2. The hemagglutination assay of GAL9 in V- bottom shaped 96-well microtiter plate.
用法
Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
儲(chǔ)存
避免反復(fù)凍融。2-8°C不超過一個(gè)月,-80°C不超過12個(gè)月。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗(yàn)決定,具體方法如下:在37°C孵育48小時(shí),沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi),在適當(dāng)?shù)臈l件下存儲(chǔ),損失率低于5%。
增值服務(wù)
相關(guān)產(chǎn)品
| 編號(hào) | 適用物種:Mus musculus (Mouse,小鼠) | 應(yīng)用(僅供研究使用,不用于臨床診斷!) | 
| APA309Mu02 | 半乳糖凝集素9(GAL9)活性蛋白 | Cell?culture;?Activity?Assays. | 
| RPA309Mu01 | 半乳糖凝集素9(GAL9)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. | 
| APA309Mu01 | 半乳糖凝集素9(GAL9)活性蛋白 | Cell?culture;?Activity?Assays. | 
| RPA309Mu02 | 半乳糖凝集素9(GAL9)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. | 
| PAA309Mu02 | 半乳糖凝集素9(GAL9)多克隆抗體 | WB; IHC | 
| PAA309Mu01 | 半乳糖凝集素9(GAL9)多克隆抗體 | WB; IHC; ICC; IP. | 
| LAA309Mu71 | 半乳糖凝集素9(GAL9)多克隆抗體(生物素標(biāo)記) | WB; IHC; ICC. | 
| SEA309Mu | 半乳糖凝集素9(GAL9)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) | Enzyme-linked immunosorbent assay for Antigen Detection. | 
| SCA309Mu | 半乳糖凝集素9(GAL9)檢測(cè)試劑盒(化學(xué)發(fā)光免疫分析法) | Chemiluminescent immunoassay for Antigen Detection. | 
| LMA309Mu | 半乳糖凝集素9(GAL9)等多因子檢測(cè)試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. | 
參考文獻(xiàn)
| 雜志 | 參考文獻(xiàn) | 
| American Journal of Nephrology | Temporal Increases in Urinary Carboxymethyllysine Correlate with Albuminuria Development in Diabetes[Karger: 328581] | 
| Clinical Immunology | Galectin-9 administration ameliorates CVB3 induced myocarditis by promoting the proliferation of regulatory T cells and alternatively activated Th2 cells[ScienceDirect: S1521661611001057] | 
| Renal Failure | Rat Renal Interstitial Fibroblasts Affect the Th1/Th2 Profile In Vitro[Pubmed: 22013937] | 
| BMC Nephrol | Serum galectin-9 levels are elevated in the patients with type 2 diabetes and chronic kidney disease[PubMed: 23339460] | 
| Retrovirology | Dysregulated Tim-3 expression on natural killer cells is associated with increased Galectin-9 levels in HIV-1 infection[PubMed: PMC3750478] | 
| PLoS One. | Upregulation of the Tim-3/Galectin-9 Pathway of T Cell Exhaustion in Chronic Hepatitis B Virus Infection[PubMed: PMC3480425] | 
| PLoS Pathogens | Galectin-9 and IL-21 Mediate Cross-regulation between Th17 and Treg Cells during Acute Hepatitis C[PubMed: PMC3688567] | 
| PLOS ONE | Graves’ Disease Is Associated with a Defective Expression of the Immune Regulatory Molecule Galectin-9 in Antigen-Presenting Dendritic Cells[PubMed: 25880730] | 
| Advances in Experimental?Medicine?and?Biology | Molecules of Damage-Associated Patterns in Bronchoalveolar Lavage Fluid and Serum in Chronic Obstructive Pulmonary Disease[Pubmed:29429028] | 
| Journal?of?Microbiology,?Immunology?and?Infection | Galectin-9-like from Angiostrongylus cantonensis young adult worms modulates eosinophil chemotaxis in vitro[Doi: 10.1016/j.jmii.2018.09.010] | 
| Oncology?Letters | The effects of Tim?3 activation on T?cells in gastric cancer progression[] | 
| Scientific Reports | Circulating levels of PD-L1 and Galectin-9 are associated with patient survival in surgically treated Hepatocellular Carcinoma independent of their intra?…[Pubmed: 31337865] | 
| Biomolecules | Blood Levels of Galectin-9, an Immuno-Regulating Molecule, Reflects the Severity for the Acute and Chronic Infectious Diseases. Biomolecules 2021, 11, 430[33804076] | 
| Medicine | Regulatory T cells, damage-associated molecular patterns, and myeloid-derived suppressor cells in bronchoalveolar lavage fluid interlinked with chronic obstructive?…[Pubmed:35687771] | 



